Kurs & Likviditet
Beskrivning
| Land | Norge |
|---|---|
| Lista | OB Match |
| Sektor | Handel & varor |
| Industri | Dagligvaror |
2023-04-20 16:42:12
20 April 2023: The Annual General Meeting of Aker BioMarine ASA was held today
as a digital meeting with online participation.
All proposals on the agenda were adopted, cf. Notice of Annual General Meeting
attached to the stock exchange release dated 28 March 2023.
The complete minutes are attached to this release.
For further information, please contact
Katrine Klaveness, CFO
Mobile: +47 991 58 915
Email: Katrine.Klaveness@akerbiomarine.com
This information is subject to the disclosure requirements pursuant to Section
5-12 of the Norwegian Securities Trading Act.
About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting
company developing krill-derived products for pharma, consumer health and
wellness as well as animal nutrition. The company has a strong position in its
industry and is the world's leading supplier of krill, the natural, powerful and
health-promoting source of nutrients from the pristine waters of Antarctica.
Aker BioMarine is listed on Oslo Stock Exchange (AKBM). More information is
available at www.akerbiomarine.com.